References
- Lenert LA, Sturley AP, Rapaport MH, et al. Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores. Schizophr Res 2004;71:155-65
- Mangalore R, Knapp M. Cost of schizophrenia in England. J. Ment Health Policy Econ 2007;10:23-41
- Knapp M, Mangalore R, Simon J. The global costs of schizophrenia. Schizophr Bull 2004;30:279-93
- Leucht S, Barnes TRE, Kissling W, et al. Relapse prevention in schizophrenia with new generation antipsychotics: a systematic review and exploratory meta-analysis of randomised, controlled trials. Am J Psychiatry 2003;160:1209-22
- Ascher-Svanum H, Zhu B, Faries D, et al. Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia. BMC Psychiatry 2006;6:8
- Stroup TS, Lieberman JA, McEvoy JP, et al. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study. Am J Psychiatry 2007;164:415-27
- Davis JM. The choice of drugs for schizophrenia. N Engl J Med 2006;354:518-20
- Ganesan S, Agambaram V, Randeree F, et al. Switching from other antipsychotics to once-daily extended release quetiapine fumarate in patients with schizophrenia. Curr Med Res Opin 2008;24(1):21-32
- Lenert LA, Rupnow MFT, Elnitsky C. Application of a disease-specific mapping function to estimate utility gains with effective treatment of schizophrenia. Health Qual Life Outcomes 2005;3:57-64
- Barnes TRE. A rating scale for drug-induced akathisia (BARS). Br J Psychiatry 1989;154:672-6
- Simpson GM, Angus JWS. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970;212(Suppl. 44):11-19
- British National Formulary: RPS Publishing. Available at: http://www.bnf.org [Last accessed 8 January 2008]
- Lfn.se [Läkemedelsförmånsnämnden]. Available at: http://www.lfn.se [Last accessed 28 January 2008]
- Sekretariat der Roten Liste GmbH: Rote Liste Online. Available at: http://www.roteliste.de [Last accessed 1 February 2008]
- Číselníky. Hromadně vyráběné léčivé přípravky a potraviny pro zvláštní lékařské účely. Účinnost od 1. května 2007, verze 621. Praha: Všeobecná zdravotní pojišťovna České republiky; 2007
- Farmadati Italia s.r.l. Compendio Farmaceutico Telematico, 2007
- Oanda.com. The currency site. Available at: http://www.oanda.com [Last accessed 12 March 2008]
- Kahn RS, Schulz C, Palazov VD, et al. Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2007;68:832-42